Clinical trials are the backbone of advancing bladder cancer research and improving patient care. Hosted by Dr. Peter Black and featuring Tony Cornacchia’s perspective as a trial-experienced patient, this 2024 webinar provides an in-depth look into the mechanics of clinical trials. Gain valuable insights into the patient’s role, expectations when participating, and the pivotal impact of bladder cancer clinical trials in advancing treatments and research.
Understanding Bladder Cancer Clinical Trials
Clinical trials are a type of research study that tests new treatments to see if they are safe and effective, and whether they may improve patient care.
In comparison, observational studies do not test new treatments. Instead, they collect information about patients’ experiences, symptoms, or quality of life to help researchers better understand the disease.
By taking part in clinical trials, patients help create reliable data that leads to safer and more effective care. Trials also give patients early access to new treatments, which can be especially important for advanced or metastatic bladder cancer.
The Patient Experience for Clinical Trials for Bladder Cancer
In the webinar, Tony Cornacchia shared his journey as a bladder cancer patient in a clinical trial. After multiple surgeries and treatments, his cancer spread to the lymph nodes. With limited options, he joined a Phase 3 immunotherapy trial instead of standard chemotherapy.
Through careful monitoring and support from the trial team, Tony achieved a complete response and continues to benefit from the treatment. His story shows that even when a trial does not work for everyone, some patients can experience significant benefits. Participation also helps advance knowledge that improves care for future patients.
Phases of Bladder Cancer Clinical Trials
Clinical trials happen in phases, and each clinical trial phase has a clear goal:
- Phase 1: Tests safety and dosing in a small group.
- Phase 2: Evaluates safety and early effectiveness in a moderate group.
- Phase 3: Compares the new treatment to standard care in large groups to see if it works.
- Phase 4: Studies long-term safety and real-world outcomes after approval.
The webinar included examples of early immunotherapy trials for metastatic bladder cancer, single-arm Phase 2 trials for non-muscle-invasive bladder cancer (NMIBC), and large Phase 3 studies testing combination therapies. Each clinical trial phase builds on the previous ones to improve safety, effectiveness, and patient outcomes.
Enrolling in Clinical Trials for Bladder Cancer
Finding the right clinical trial can be challenging. Patients should talk with their urologist or medical oncologist to find a suitable trial.
Once enrolled, patients are closely monitored with regular scans, bloodwork, and check-ins. They can leave a trial at any time without penalty, and many trials help with travel or financial costs.
How to Get Involved in Clinical Trials for Bladder Cancer Canada
Participation in bladder cancer clinical trials helps research that benefits future patients while giving participants high-quality care.
If you or a loved one would like to learn more about bladder cancer clinical trials, visit our clinical trial page. To enroll in our internal studies and surveys visit Bladder Cancer Canada’s patient study recruitment page for details on current opportunities and guidance on enrollment.
